Kusurinomadoguchi (5592) Q1 2027 earnings summary

Executive summary

• Achieved record consolidated revenue and operating profit in Q1 FY2027, driven by growth in healthcare automation, core system businesses, M&A, and regulatory tailwinds.

• Strategic business realignment and AI-driven automation initiatives are addressing labor shortages and advancing healthcare DX.

• The company rebranded its business segments to reflect a focus on AI-driven healthcare solutions.

• The business environment remains uncertain due to global raw material price hikes and geopolitical factors, but IT and AI adoption in healthcare is seen as a growth opportunity.

Financial highlights

• Consolidated revenue: ¥3,643.9 million, up 25.0% year-over-year; operating profit: ¥784.1 million, up 24.6% year-over-year; net income attributable to parent: ¥623.0 million, up 61.0% year-over-year.

• EBITDA: ¥1,194 million, up 22.0% year-over-year; EPS for Q1 FY2027 was ¥54.43, up from ¥34.47 in the prior year.

• Gross profit: ¥2,099.1 million, up 24.3% year-over-year.

• Operating margin improved, with operating profit at 21.5% of sales.

• Comprehensive income for Q1 FY2027 was ¥605.8 million, up 47.2% year-over-year.

Outlook and guidance

• FY2027 full-year guidance: revenue ¥14,400 million (+16.8%), operating profit ¥3,100 million (+15.6%), net income ¥3,100 million (+5.0%), EPS ¥270.53.

• Dividend forecast raised to ¥40.00 per share for FY2027, up from ¥38.00.

• Q1 progress rates for revenue, operating profit, and ordinary profit all at 25% of full-year targets.

• Medium-term plan targets ¥20 billion in stock revenue and ¥5 billion in operating profit by FY2030, with a goal to expand to 100,000 facilities.